Most people think of trauma as a psychological wound. Something that happened got encoded as a bad memory, and now needs to be processed, managed, or suppressed.
But what if trauma is also a structural one? And what if psychedelics hold the key to long term recovery?
A new study published in Biological Psychiatry has found that PTSD doesn’t just rewire how you think and feel. It physically damages myelin, the insulation of your brain’s communication network. And psilocybin and MDMA, two compounds at the centre of the psychedelic therapy revolution, appear to rebuild it.
The Missing Piece Of Neuroplasticity
When researchers started studying how psilocybin and MDMA help people recover from PTSD, they focused almost exclusively on neurons and synapses (junction where neurons communicate). The classic “neuroplasticity” story that these compounds loosen entrenched patterns, open a window of plasticity, and allow new connections to form.
All of that is real. But it turns out there was a major part of the story nobody was talking about. Myelin.
Accounting for approximately 50% of brain volume, myelin is the insulating sheath that wraps around nerve fibres, produced by specialised cells called oligodendrocytes. Think of it less like bubble wrap around a wire, and more like the living connective tissue that determines when and how fast signals travel between nodes in a network.
Myelin does more than just protect axons (the long projections of neurons that transmit electrical impulses). It synchronises them. It determines the timing of communication across brain circuits. And when that timing goes wrong, entire networks lose their coherence. So myelin is pretty important.
Myelin is also important for energy regulation and myelin loss plays a central and underappreciated role in driving the energy deficits characteristic of aging and neurodegenerative conditions.
And trauma, it turns out, can damage myelin. It’s not visibly on a standard scan, but at the level of the dentate gyrus (part of the hippocampus, your brain’s memory and context centre), fear conditioning produces measurable disruption to the oligodendroglial architecture. So the signal still travels, but the rhythm is off due to the damaged structure. And a brain with disrupted timing is a brain that keeps misfiring the threat response, stuck in a loop it can’t exit.
This is what PTSD looks like, structurally. Put simple, it’s a network that’s lost its synchrony.
The Study
The study, led by Mehmet Bostancıklıoğlu at Gaziantep University, used a rat model of contextual fear conditioning (essentially, a PTSD analogue) and administered low repeated doses of either psilocybin (0.5mg/kg for 4 days) or MDMA (0.1mg/kg for 4 days). Then they went deep, combining behavioural assessment with electron microscopy, transcriptomics, proteomics, and metabolomics, five converging lines of evidence across biological scales.
Both compounds triggered a significant increase in mature oligodendrocytes in the dentate gyrus. Both upregulated myelin-related proteins. Both produced convergent multi-omic signatures pointing to active remyelination, the physical re-insulation of networks that trauma had disrupted.
The researchers went further. When they experimentally stripped myelin from the hippocampus, the anxiolytic effects of both compounds largely disappeared. The drugs couldn’t do their job without intact myelin. When they then added a promyelinating agent to demyelinated animals receiving psilocybin or MDMA, the therapeutic effects were partially restored.
The conclusion is unavoidable: myelin repair is a fundamental part of psychedelic healing.
The Signalling Chain
Both compounds work through a shared serotonergic pathway. When the researchers blocked 5-HT2A receptors, the remyelination effects vanished entirely, along with the behavioural improvements. So the same receptor that drives the psychedelic experience, that characteristic dissolution of self and loosening of rigid patterns, is also the receptor that initiates structural repair in the supporting cells of your neural network.
Here’s how the cascade appears to work:
Psilocybin and MDMA activate 5-HT2A receptors and simultaneously upregulate BDNF-TrkB and mTOR signalling pathways. These are exactly the pathways required for oligodendrocyte precursor cells (OPCs) to mature and begin laying down new myelin.
There’s one more finding worth dwelling on. When the team used a protein synthesis inhibitor to block fear memory consolidation entirely, anxiety dropped, but the myelin remained unrepaired. This is a critical point that shows you can suppress the memory trace and feel better in the short term, but the physical damage of the trauma on the myelin remains.
There’s a gap between symptomatic relief and structural recovery. And psychedelics close that gap.
The Neuroplastic Window
There’s a concept in psychedelic science called the neuroplastic window, which is the period after a psychedelic session during which the brain is in a heightened state of malleability. This is the rationale for post-experience integration and doing therapy after the experience.
This study suggests the window isn’t just about neural excitability or synaptic flexibility. It may be structurally held open by active remyelination.
The changes observed in the myelin take place over days. And they’re activity-dependent. The myelin being laid down during this period is stabilising the new network patterns that the experience made possible.
Therapy, movement, new relational patterns, novel environments during this window aren’t just psychologically useful. They may literally determine which circuits get remyelinated, which new timings get locked in, which parts of the network get rebuilt for the long term.
lead investigator Dr. Mehmet Bostancıklıoğlu explains, “We often talk about psychedelics as ‘opening a window’ for brain plasticity. Recent work emphasizes that these drugs can acutely loosen entrenched network patterns and then leave a sub-acute period in which experience can reshape circuits.
“What we show here is that myelin-producing cells may be an underappreciated part of that story—helping translate a transient window into longer-lasting circuit change, at least in a fear-based rat model.”
The Bigger Picture
This study was conducted in rats. The extrapolation to human PTSD has to be made carefully.
But it does makes a compelling case that we’ve been looking at an incomplete picture when it comes to psychedelic-induced neuroplasticity.
Myelin and remyelination appear to be vital to the process. and understanding that changes how we think about integration, dosing protocols, and long term recovery.
